Schizoaffecitve Disorder: Clinical Trials

7 trials for Schizoaffecitve Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 2 not yet recruiting, 1 completed. 4 Phase 2, 3 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Completed 1, Not yet recruiting 1
Not applicable3Recruiting 2, Not yet recruiting 1
Phase 11Recruiting 1

Follow Schizoaffecitve Disorder: new trials by email Literature Review of Schizoaffecitve Disorder trials Research Report on Schizoaffecitve Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia
Decoded Neurofeedback - Schizophrenia Disorder, Schizoaffecitve Disorder
Not applicableNot yet recruitingColumbia University512026-12-012026-10-14
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Deferiprone (DFP), N-Acetyl Cysteine (NAC) - Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder
Phase 2RecruitingAmit Lotan802026-08-122026-09-29
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
Digital therapeutic (AffectUs), Psychoeducational materials - Schizophrenia, Schizoaffecitve Disorder
Not applicableRecruitingSamsung Medical Center602026-07-152026-08-21
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Xanomeline and trospium chloride (KarXT) - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 1 / Phase 2RecruitingNew York State Psychiatric Institute122026-07-012026-07-14
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
Mindfulness-Based Virtual Reality Intervention - Schizophrenia Disorder, Schizoaffecitve Disorder
Not applicableRecruitingManhattan Psychiatric Center582026-06-052026-06-10
Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
EEG Neurofeedback - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder
Phase 2Not yet recruitingUniversity of California, San Diego1042026-06-012026-05-18
Glycine to Treat Psychotic Disorders in Children
Glycine - Psychotic Disorder, Schizoaffecitve Disorder
Phase 2CompletedNational Institute of Mental Health (NIMH)102000-05-012008-03-04

Narrower conditions

Schizophrenia (6)  ·  Psychotic Disorders (2)  ·  Aggression (1)  ·  Emotional Regulation (1)  ·  Hallucinations (1)

Broader conditions

Mental Disorders (6)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (6)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Self-Control (1)  ·  Signs and Symptoms (1)  ·  Social Behavior (1)

Interventions

Acetylcysteine (1)  ·  Deferiprone (1)  ·  Glycine (1)  ·  trospium chloride (1)  ·  xanomeline (1)

Sponsors

Amit Lotan (1)  ·  Columbia University (1)  ·  Manhattan Psychiatric Center (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  New York State Psychiatric Institute (1)  ·  Samsung Medical Center (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Israel (1)  ·  South Korea (1)

Top investigators

Anzalee Khan, PhD (1)  ·  Fiza Singh, MD (1)  ·  Guillermo Horga, MD, PhD (1)  ·  Jean-Pierre Lindenmayer, MD (1)  ·  Joshua Kantrowitz, MD (1)  ·  Joshua T Kantrowitz, MD (1)  ·  Jung-Seok Choi, M.D. (1)  ·  Ragy Girgis, MD (1)

NIH funding

R61MH133785 (1), R61MH143195 (1)